series-a
Stage
2020
Founded
2
Investors
About
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics, primarily focusing on ketamine-based and psychedelic combination therapies for mental health disorders such as depression and PTSD.
Explore Freedom Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.